DaVita Aktie
WKN: 897914 / ISIN: US23918K1088
01.02.2023 11:00:00
|
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call
DENVER, Feb. 1, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after the market closes the same day.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Wednesday, February 22, 2023
Starting at 5:00 p.m. EST
Dial in number: 877-918-6630
International dial in: 517-308-9042
Webcast: Link
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2022, DaVita served 200,000 patients at 2,776 outpatient dialysis centers in the United States. The company also operated 352 outpatient dialysis centers in 11 other countries worldwide. DaVita has worked collaboratively to help propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-4th-quarter-2022-investor-conference-call-301735573.html
SOURCE DaVita

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DaVita Inc Registered Shsmehr Nachrichten
24.03.25 |
S&P 500-Papier DaVita-Aktie: So viel Gewinn hätte ein Investment in DaVita von vor 10 Jahren abgeworfen (finanzen.at) | |
17.03.25 |
S&P 500-Papier DaVita-Aktie: So viel hätten Anleger mit einem Investment in DaVita von vor 5 Jahren verdient (finanzen.at) | |
10.03.25 |
Handel in New York: S&P 500 beendet die Sitzung mit Verlusten (finanzen.at) | |
10.03.25 |
S&P 500-Wert DaVita-Aktie: So viel Gewinn hätte ein Investment in DaVita von vor 3 Jahren abgeworfen (finanzen.at) | |
03.03.25 |
S&P 500-Wert DaVita-Aktie: So viel hätten Anleger mit einem Investment in DaVita von vor einem Jahr verdient (finanzen.at) | |
24.02.25 |
S&P 500-Titel DaVita-Aktie: So viel Gewinn hätte eine DaVita-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
20.02.25 |
Donnerstagshandel in New York: S&P 500 legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
17.02.25 |
S&P 500-Titel DaVita-Aktie: So viel Gewinn hätte ein DaVita-Investment von vor 5 Jahren eingefahren (finanzen.at) |
Analysen zu DaVita Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
DaVita Inc Registered Shs | 140,50 | 0,36% |
|